Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.10.5789

High Mobility Group Box 1 Protein Is Methylated and Transported to Cytoplasm in Clear Cell Renal Cell Carcinoma  

Wu, Fei (Department of Urology, Provincial Hospital Affiliated to Shandong University)
Zhao, Zuo-Hui (Department of Urology, Provincial Hospital Affiliated to Shandong University)
Ding, Sen-Tai (Department of Urology, Provincial Hospital Affiliated to Shandong University)
Wu, Hai-Hu (Department of Urology, Provincial Hospital Affiliated to Shandong University)
Lu, Jia-Ju (Department of Urology, Provincial Hospital Affiliated to Shandong University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.10, 2013 , pp. 5789-5795 More about this Journal
Abstract
Background: The high mobility group box 1 (HMGB1) protein is a widespread nuclear protein present in most cell types. It typically locates in the nucleus and functions as a nuclear cofactor in transcription regulation. However, HMGB1 can also localize in the cytoplasm and be released into extracellular matrix, where it plays critical roles in carcinogenesis and inflammation. However, it remains elusive whether HMGB1 is relocated to cytoplasm in clear cell renal cell carcinoma (ccRCC). Methods: Nuclear and cytoplasmic proteins were extracted by different protocols from 20 ccRCC samples and corresponding adjacent renal tissues. Western blotting and immunohistochemistry were used to identify the expression of HMGB1 in ccRCC. To elucidate the potential mechanism of HMGB1 cytoplasmic translocation, HMGB1 proteins were enriched by immunoprecipitation and analyzed by mass spectrometry (MS). Results: The HMGB1 protein was overexpressed and partially localized in cytoplasm in ccRCC samples (12/20, 60%, p<0.05). Immunohistochemistry results indicated that ccRCC of high nuclear grade possess more HMGB1 relocation than those with low grade (p<0.05). Methylation of HMGB1 at lysine 112 in ccRCC was detected by MS. Bioinformatics analysis showed that post-translational modification might affect the binding ability to DNA and mediate its translocation. Conclusion: Relocation of HMGB1 to cytoplasm was confirmed in ccRCC. Methylation of HMGB1 at lysine 112 might the redistribution of this cofactor protein.
Keywords
HMGB1; methylation; RCC; renal cancer; transcription regulation; cytoplasmic location;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Curtin J F, Liu N, Candolfi M, et al (2009). HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med, 6, e10.   DOI   ScienceOn
2 Ellerman JE, Brown CK, de Vera M, et al (2007). Masquerader: high mobility group box-1 and cancer. Clin Cancer Res, 13, 2836-48.   DOI   ScienceOn
3 Evankovich J, Cho SW, Zhang R, et al (2010). High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J Biol Chem, 285, 39888-97.   DOI   ScienceOn
4 Gauley J and Pisetsky DS (2009). The translocation of HMGB1 during cell activation and cell death. Autoimmunity, 42, 299-301.   DOI   ScienceOn
5 Goodwin GH, Johns EW (1977). The isolation and purification of the high mobility group (HMG) nonhistone chromosomal proteins. Methods Cell Biol, 16, 257-67.   DOI
6 Gupta K, Miller JD, Li JZ, et al (2008). Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev, 34, 193-205.   DOI   ScienceOn
7 Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70.   DOI   ScienceOn
8 Jung Y and Lippard S J (2003). Nature of full-length HMGB1 binding to cisplatin-modified DNA. Biochemistry, 42, 2664-71.   DOI   ScienceOn
9 Hoppe G, Talcott KE, Bhattacharya SK, et al (2006). Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp Cell Res, 312, 3526-38.   DOI   ScienceOn
10 Jiao Y, Wang HC, Fan S J (2007). Growth suppression and radiosensitivity increase by HMGB1 in breast cancer. Acta Pharmacol Sin, 28, 1957-67.   DOI   ScienceOn
11 Kang HJ, Lee H, Choi HJ, et al (2009). Non-histone nuclear factor HMGB1 is phosphorylated and secreted in colon cancers. Lab Invest, 89, 948-59.   DOI   ScienceOn
12 Knapp S, Muller S, Digilio G, et al (2004). The long acidic tail of high mobility group box 1 (HMGB1) protein forms an extended and flexible structure that interacts with specific residues within and between the HMG boxes. Biochemistry, 43, 11992-7.   DOI   ScienceOn
13 Kovacs G, Akhtar M, Beckwith BJ, et al (1997). The Heidelberg classification of renal cell tumours. J Pathol, 183, 131-3.   DOI
14 Lee KB, Thomas JO (2000). The effect of the acidic tail on the DNA-binding properties of the HMG1,2 class of proteins: insights from tail switching and tail removal. J Mol Biol, 304, 135-49.   DOI   ScienceOn
15 Krynetski EY, Krynetskaia NF, Bianchi ME, Evans WE (2003). A nuclear protein complex containing high mobility group proteins B1 and B2, heat shock cognate protein 70, ERp60, and glyceraldehyde-3-phosphate dehydrogenase is involved in the cytotoxic response to DNA modified by incorporation of anticancer nucleoside analogues. Cancer Res, 63, 100-6.
16 Lee H, Park M, Shin N, et al (2012). High mobility group box-1 is phosphorylated by protein kinase C zeta and secreted in colon cancer cells. Biochem Biophys Res Commun, 424, 321-6.   DOI   ScienceOn
17 Lotze MT, DeMarco RA (2003). Dealing with death: HMGB1 as a novel target for cancer therapy. Curr Opin Investig Drugs, 4, 1405-9.
18 Li J, Kokkola R, Tabibzadeh S, et al (2003). Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med, 9, 37-45.
19 Lin L, Zhong K, Sun Z, et al (2012). Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma. J Cancer Res Clin Oncol, 138, 11-22.   DOI   ScienceOn
20 Lotze M T and Tracey K J (2005). High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol, 5, 331-42.   DOI   ScienceOn
21 Luo Y, Chihara Y, Fujimoto K, et al (2012). High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy. Eur J Cancer, 49, 741-51.
22 Read CM, Cary PD, Crane-Robinson C, et al (1993). Solution structure of a DNA-binding domain from HMG1. Nucleic Acids Res, 21, 3427-36.   DOI   ScienceOn
23 Na S, Bandeira N, Paek E (2012). Fast multi-blind modification search through tandem mass spectrometry. Mol Cell Proteomics, 11, M111 010199.   DOI   ScienceOn
24 Pasheva EA, Pashev IG, Favre A (1998). Preferential binding of high mobility group 1 protein to UV-damaged DNA. Role of the COOH-terminal domain. J Biol Chem, 273, 24730-6.   DOI   ScienceOn
25 Peters R (1986). Fluorescence microphotolysis to measure nucleocytoplasmic transport and intracellular mobility. Biochim Biophys Acta, 864, 305-59.   DOI   ScienceOn
26 Pettersen EF, Goddard TD, Huang CC, et al (2004). UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem, 25, 1605-12.   DOI   ScienceOn
27 Pil P M, Lippard S J (1992). Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science, 256, 234-7.   DOI
28 Ramstein J, Locker D, Bianchi ME, Leng M (1999). Domain-domain interactions in high mobility group 1 protein (HMG1). Eur J Biochem, 260, 692-700.   DOI   ScienceOn
29 Rini BI, Campbell SC, Escudier B (2009). Renal cell carcinoma. Lancet, 373, 1119-32.   DOI   ScienceOn
30 Sabio G, Arthur JS, Kuma Y, et al (2005). p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J, 24, 1134-45.   DOI   ScienceOn
31 Tang D, Kang R, Zeh HJ, 3rd, Lotze MT (2010). High-mobility group box 1 and cancer. Biochim Biophys Acta, 1799, 131-40.   DOI   ScienceOn
32 Scaffidi P, Misteli T, Bianchi ME (2002). Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 418, 191-5.   DOI   ScienceOn
33 Stott K, Watson M, Howe FS, et al (2010). Tail-mediated collapse of HMGB1 is dynamic and occurs via differential binding of the acidic tail to the A and B domains. J Mol Biol, 403, 706-22.   DOI   ScienceOn
34 Stros M, Stokrova J, Thomas J O (1994). DNA looping by the HMG-box domains of HMG1 and modulation of DNA binding by the acidic C-terminal domain. Nucleic Acids Res, 22, 1044-51.   DOI
35 Stros M, Ozaki T, Bacikova A, et al (2002). HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73- dependent sequence-specific transactivation from the human Bax gene promoter. J Biol Chem, 277, 7157-64.   DOI   ScienceOn
36 Taguchi A, Blood DC, del Toro G, et al (2000). Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature, 405, 354-60.   DOI   ScienceOn
37 Tan F, Lu L, Cai Y, et al (2008). Proteomic analysis of ubiquitinated proteins in normal hepatocyte cell line Chang liver cells. Proteomics, 8, 2885-96.   DOI   ScienceOn
38 Teo SH, Grasser KD, Thomas JO (1995). Differences in the DNA-binding properties of the HMG-box domains of HMG1 and the sex-determining factor SRY. Eur J Biochem, 230, 943-50.   DOI
39 Tian J, Avalos AM, Mao SY, et al (2007). Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol, 8, 487-96.   DOI   ScienceOn
40 Tsung A, Klune JR, Zhang X, et al (2007). HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calciummediated signaling. J Exp Med, 204, 2913-23.   DOI   ScienceOn
41 Webb M, Thomas JO (1999). Structure-specific binding of the two tandem HMG boxes of HMG1 to four-way junction DNA is mediated by the A domain. J Mol Biol, 294, 373-87.   DOI   ScienceOn
42 Weir HM, Kraulis PJ, Hill CS, et al (1993). Structure of the HMG box motif in the B-domain of HMG1. EMBO J, 12, 1311-9.
43 Yang H, Antoine DJ, Andersson U, and Tracey KJ (2013). The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol, 93, 865-73.   DOI   ScienceOn
44 Youn JH, Shin JS (2006). Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol, 177, 7889-97.   DOI
45 Bonaldi T, Langst G, Strohner R, et al (2002). The DNA chaperone HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding. EMBO J, 21, 6865-73.   DOI   ScienceOn
46 Bianchi ME, Beltrame M, Paonessa G (1989). Specific recognition of cruciform DNA by nuclear protein HMG1. Science, 243, 1056-9.   DOI
47 Alao JP, Gamble SC, Stavropoulou AV, et al (2006). The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines. Mol Cancer, 5, 7.   DOI   ScienceOn
48 Apetoh L, Ghiringhelli F, Tesniere A, et al (2007). Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med, 13, 1050-9.   DOI   ScienceOn
49 Assenberg R, Webb M, Connolly E, et al (2008). A critical role in structure-specific DNA binding for the acetylatable lysine residues in HMGB1. Biochem J, 411, 553-61.   DOI   ScienceOn
50 Banerjee S, Kundu TK (2003). The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcription. Nucleic Acids Res, 31, 3236-47.   DOI   ScienceOn
51 Bonaldi T, Talamo F, Scaffidi P, et al (2003). Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J, 22, 5551-60.   DOI   ScienceOn
52 Campana L, Bosurgi L, Rovere-Querini P (2008). HMGB1: a two-headed signal regulating tumor progression and immunity. Curr Opin Immunol, 20, 518-23.   DOI   ScienceOn
53 Carneiro V C, de Moraes Maciel R, de Abreu da Silva IC, et al (2009). The extracellular release of Schistosoma mansoni HMGB1 nuclear protein is mediated by acetylation. Biochem Biophys Res Commun, 390, 1245-9.   DOI   ScienceOn
54 Chandrasekharan MB, Huang F, Sun ZW (2010). Histone H2B ubiquitination and beyond: Regulation of nucleosome stability, chromatin dynamics and the trans-histone H3 methylation. Epigenetics, 5, 460-8.   DOI   ScienceOn
55 Sessa L, Bianchi ME (2007). The evolution of High Mobility Group Box (HMGB) chromatin proteins in multicellular animals. Gene, 387, 133-40.   DOI   ScienceOn
56 de Abreu da Silva IC, Carneiro VC, Maciel Rde M, et al (2011). CK2 phosphorylation of Schistosoma mansoni HMGB1 protein regulates its cellular traffic and secretion but not its DNA transactions. PLoS One, 6, e23572.   DOI
57 Ito I, Fukazawa J, Yoshida M (2007). Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J Biol Chem, 282, 16336-44.   DOI   ScienceOn
58 Motzer RJ, Hutson TE, Tomczak P, et al (2007). Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med, 356, 115-24.   DOI   ScienceOn
59 Wang H, Bloom O, Zhang M, et al (1999). HMG-1 as a late mediator of endotoxin lethality in mice. Science, 285, 248-51.   DOI   ScienceOn